Phase II multicenter trial of the histone deactylase inhibitor (HDACi) belinostat, carboplatin and paclitaxel (BelCaP) in patients (pts) with relapsed epithelial ovarian cancer (EOC) Meeting Abstract

Industry Collaboration International Collaboration

cited authors

  • Finkler, N. J., Dizon, D. S., Braly, P., Micha, J., Lassen, U., Celano, P., Glasspool, R., Crowley, E., Buhl-Jensen, P., Penson, R. T.

Publication Date

  • May 20, 2008

webpage

published in

category

volume

  • 26

issue

  • 15

WoS Citations

  • 0

WoS References

  • 0